Epidemic risk is a major threat. In the last decade, there have been over 400 high-priority human disease outbreaks which have impacted the stability of economies and corporations. The Zika virus alone may end up costing Latin America and the Caribbean up to $18bn, and the South Korean MERS outbreak in 2015 caused a 40% drop in tourism, leading to an estimated $900m drop in revenue.
Metabiota has created a comprehensive and objective methodology for quantifying the potential impact of epidemic risk. The company’s methodology comprises both data experts and on-the-ground specialists. It provides underwriters with tools to analyse and quantify the financial impact of epidemics for use in their underwriting processes. Separately, it works with industry (e.g. sports clubs) to understand the impact of epidemics on their businesses.Read more »